Skip to content

US · SNWV · MEDICAL - EQUIPMENT & SERVICES

SANUWAVE Health Inc. (SNWV) intrinsic value and stock valuation

$1.50as of 2026-11-21 · Mkt cap 51.34M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

SANUWAVE Health Inc. DCF and intrinsic value

InvestorsCraft values SNWV with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from SNWV’s statements →

SANUWAVE Health Inc. Graham Number

Graham Number: $2.42d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Equipment & Services Eden Prairie, MN 55344 sanuwave.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$44.1M+61.1% 5y CAGRd
20112025
Net income
$11.8M
20112025
Free cash flow
$1.93M
20112025
Total equity
$1.62M
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$44.1M$32.6M$20.4M$16.7M$13M
Operating income$4.95M$5.42M-$-540K-$-8.95M-$-14.14M
Net income$11.8M-$-31.37M-$-25.81M-$-10.29M-$-27.26M
EPSd$1.3M-$-7.03M-$-12.17M-$-7M-$-19.75M
Operating cash flow$3.88M$2.46M-$-4.54M-$-17.17M-$-6.41M
Capital expenditure-$-1.94M-$-490K$0.00$1.02M-$-530K
Free cash flow$1.93M$1.97M-$-4.54M-$-16.15M-$-6.94M
Total assets$37.3M$30.1M$22.4M$19.9M$18.6M
Total debt$23M$25.5M$30.5M$39M$28.4M
Net debt$11M$15.3M$28.7M$37.8M$27.8M
Total equity$1.62M-$-12.72M-$-43.18M-$-41.01M-$-38.96M
Cash and short-term investments$12M$10.2M$1.8M$1.15M$620K
Income statement
20252024202320222021
Revenue$44.1M$32.6M$20.4M$16.7M$13M
Cost of revenue$10.1M$8.08M$6.04M$4.33M$4.99M
Gross profit$34M$24.6M$14.4M$12.4M$8.02M
Research and development expenses$1.35M$670K$580K$570K$1.1M
Selling, general and administrative expenses$26.8M$17.7M$13.6M$20M$20.3M
Other expenses$880K$790K$750K$770K$780K
Operating expenses$29M$19.1M$14.9M$21.4M$22.2M
Cost and expenses$39.1M$27.2M$20.9M$25.7M$27.2M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$6.25M$13.6M$15.6M$14.1M$7.09M
Depreciation and amortization$1.28M$1.15M$1.03M$950K$1.24M
Ebitda$19.4M-$-16.56M-$-9.15M$4.79M-$-18.9M
Operating income$4.95M$5.42M-$-540K-$-8.95M-$-14.14M
Total other income/expenses, net$6.95M-$-36.76M-$-25.26M-$-1.34M-$-13.09M
Income before tax$11.9M-$-31.34M-$-25.8M-$-10.29M-$-27.23M
Income tax expense$90K$30K$0.00$0.00$30K
Net income$11.8M-$-31.37M-$-25.81M-$-10.29M-$-27.26M
Weighted average shares outstanding$8.56M$4.46M$2.12M$1.47M$1.38M
Weighted average diluted shares outstanding$9.08M$4.46M$2.12M$1.47M$1.38M
Balance sheet
20252024202320222021
Cash and short-term investments$12M$10.2M$1.8M$1.15M$620K
Net receivables$5.42M$3.33M$3.31M$4.03M$2.42M
Inventory$5.93M$4.15M$2.95M$870K$1.04M
Total current assets$24.6M$18.4M$9.78M$6.62M$4.4M
Property, plant and equipment, net$2.36M$730K$940K$860K$1.01M
Goodwill and intangible assets$10.3M$11M$11.7M$12.4M$13.1M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$12.7M$11.7M$12.6M$13.3M$14.2M
Total assets$37.3M$30.1M$22.4M$19.9M$18.6M
Accounts payable$3.22M$3.73M$5.71M$4.4M$7.64M
Short-term debt$5.79M$25.3M$30M$38.5M$27.4M
Deferred revenue$390K$190K$90K$60K$50K
Total current liabilities$17.9M$42.3M$64.8M$60.2M$56.3M
Long-term debt$17.2M$190K$490K$440K$990K
Deferred revenue, non-current$700K$300K$350K$230K$290K
Total non-current liabilities$17.9M$490K$840K$670K$1.31M
Capital lease obligations$1.01M$190K$490K$440K$390K
Total liabilities$35.7M$42.8M$65.6M$60.9M$57.6M
Common stock$10K$10K$0.00$550K$480K
Retained earnings-$-242.69M-$-251.42M-$-220.05M-$-194.24M-$-183.95M
Accumulated other comprehensive income (loss)$10K$10K-$-110K-$-70K-$-70K
Total equity$1.62M-$-12.72M-$-43.18M-$-41.01M-$-38.96M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$23M$25.5M$30.5M$39M$28.4M
Net debt$11M$15.3M$28.7M$37.8M$27.8M
Cash flow statement
20252024202320222021
Net income$11.8M-$-31.37M-$-25.81M-$-10.29M-$-27.26M
Depreciation and amortization$1.28M$1.15M$1.03M$950K$1.24M
Stock-based compensation$0.00$1.51M$0.00$0.00$0.00
Change in working capital-$-4.01M-$-2.9M-$-3.61M-$-1.12M$9.93M
Accounts receivable-$-2.3M-$-490K-$-50K-$-1.75M-$-400K
Inventory-$-2.28M-$-1.2M-$-2.8M-$-70K$1.69M
Accounts payable-$-520K-$-1.42M$1.55M-$-2.55M$3.18M
Net cash provided by operating activities$3.88M$2.46M-$-4.54M-$-17.17M-$-6.41M
Investments in property, plant and equipment-$-1.94M-$-490K$0.00$1.02M-$-530K
Acquisitions, net$0.00$0.00$0.00$330K$0.00
Net cash used for investing activities$3.43M-$-490K$20K$330K-$-530K
Common stock issued$560K$10.3M$0.00$100K$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-5.59M$6.35M$5.21M$17.4M$5.12M
Net change in cash$1.72M$8.44M$640K$530K-$-1.82M
Cash at end of period$12M$10.2M$1.8M$1.15M$620K
Operating cash flow$3.88M$2.46M-$-4.54M-$-17.17M-$-6.41M
Capital expenditure-$-1.94M-$-490K$0.00$1.02M-$-530K
Free cash flow$1.93M$1.97M-$-4.54M-$-16.15M-$-6.94M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About SANUWAVE Health Inc.

        SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.

        CEO
        Morgan C. Frank
        Employees
        55
        Beta
        1.42

        Explore

        Frequently asked questions

        What is the intrinsic value of SANUWAVE Health Inc. (SNWV)?

        InvestorsCraft does not currently publish an intrinsic value for SNWV. How the IC value is calculated.

        Is SNWV undervalued?

        InvestorsCraft does not publish an undervaluation signal for SNWV at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.